Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,045
datasets available to search
ShareScore release 0.9.0
Dataset results
1,045 results for “neoadjuvant chemotherapy”
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patient
ClinicalTrials.gov study NCT04301739. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
ClinicalTrials.gov study NCT07132463. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled,
ClinicalTrials.gov study NCT05891080. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06975644. IPD Sharing: NO. Countries: 0. Publications: 0.
To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06470633. IPD Sharing: NO. Countries: 0. Publications: 0.
Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy
ClinicalTrials.gov study NCT06418139. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC
ClinicalTrials.gov study NCT06037655. IPD Sharing: NO. Countries: 0. Publications: 0.
QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06852456. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05253066. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
ClinicalTrials.gov study NCT05340231. IPD Sharing: NO. Countries: 0. Publications: 0.
RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT05134519. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT04713761. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients
ClinicalTrials.gov study NCT04677673. IPD Sharing: NO. Countries: 0. Publications: 0.
Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
ClinicalTrials.gov study NCT05993559. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
ClinicalTrials.gov study NCT07401654. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
ClinicalTrials.gov study NCT06375109. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
ClinicalTrials.gov study NCT00461344. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT03647280. IPD Sharing: NO. Countries: 0. Publications: 0.
Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT01956513. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
ClinicalTrials.gov study NCT05251766. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.